For research use only. Not for therapeutic Use.
Silodosin is an α1-adrenoceptor antagonist approved for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate). Since silodosin has high affinity for the α1A adrenergic receptor, it causes practically no orthostatic hypotension (in contrast to other α1 blockers). On the other side, the high selectivity seems to be the cause of silodosin/’s typical side effect of retrograde ejaculation.
CAS Number | 160970-54-7 |
Synonyms | 160970-54-7; Rapaflo; Urief; Silodyx; Urorec |
Molecular Formula | C25H32F3N3O4 |
Purity | ≥95% |
Target | Neuronal Signaling |
Solubility | Soluble in DMSO > 10 mM |
Storage | -20°C |
InChI | 1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1 |
InChIKey | PNCPYILNMDWPEY-QGZVFWFLSA-N |
SMILES | CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F |
Reference | 1: Patil SB, Ranka K, Kundargi VS, Guru N. Comparison of tamsulosin and silodosin 2: Elgalaly H, Eliwa A, Seleem M, Salem E, Omran M, Shello H, Abdelwahab K, <br> 4: Fukuhara S. Editorial Comment to Silodosin versus naftopidil in the treatment 5: Manohar CMS, Nagabhushana M, Karthikeyan VS, Sanjay RP, Kamath AJ, 6: Tanaka Y, Tanuma Y, Masumori N. The Persistence of Silodosin Monotherapy and 7: Shah PA, Shrivastav PS. Determination of silodosin and its active glucuronide <br> <br> <br> |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |